Company Filing History:
Years Active: 2003-2010
Title: Norihiro Fukuyama: Innovator in Pharmaceutical Chemistry
Introduction
Norihiro Fukuyama is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for producing important medical compounds. With a total of 3 patents to his name, Fukuyama's work has the potential to impact various therapeutic areas.
Latest Patents
Fukuyama's latest patents include a process for producing carbostyril derivatives. This invention provides a method for synthesizing carbostyril derivatives, which are known to be useful as medical drugs, including antithrombotic agents, cerebral circulation improvers, anti-inflammatory agents, and antiulcer agents. The process allows for high yield and purity by reacting a carbostyril derivative with a tetrazole derivative in the presence of a phase transfer catalyst.
Another notable patent is the process for producing cilostazol. This invention outlines an improved and environmentally friendly method for synthesizing cilostazol, a compound useful in pharmaceuticals. The process involves reacting a carbostyril derivative with a tetrazole derivative in the presence of an inorganic basic compound in a specific solvent system, ensuring high yield and purity.
Career Highlights
Fukuyama is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the field of drug development. His expertise in chemical processes has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Fukuyama has collaborated with notable colleagues, including Michiaki Tominaga and Akihiro Yamamoto. These collaborations have further enhanced his research and development efforts, leading to advancements in pharmaceutical chemistry.
Conclusion
Norihiro Fukuyama's contributions to pharmaceutical chemistry through his innovative processes for producing medical compounds highlight his importance as an inventor. His work not only advances scientific knowledge but also has the potential to improve patient care through the development of effective medications.